Meditherapy announced that it has received KRW 26,000,000,000 in a round of funding on April 9, 2024. The transaction included participation from new investors Company K Partners Limited, Korea Investment Partners Co. Ltd. and DSC Investment Inc.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,950 KRW | -1.28% | +0.58% | +4.20% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,950 KRW | -1.28% | +0.58% | 81.21M | ||
3,805 KRW | -0.13% | +1.60% | 74.55M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.20% | 81.21M | |
+14.40% | 3.05B | |
+12.82% | 2.06B | |
+8.43% | 1.51B | |
-11.54% | 1.2B | |
+11.49% | 756M | |
+28.93% | 570M | |
-4.17% | 503M | |
+29.04% | 466M | |
+3.90% | 309M |
- Stock Market
- Equities
- A307930 Stock
- News Company K Partners Limited
- Meditherapy announced that it has received KRW 26 billion in funding from Company K Partners Limited, Korea Investment Partners Co. Ltd., DSC Investment Inc.